论文部分内容阅读
Aim: We are pursuing potent BACE1 inhibitors in an effort to identify suitable AD drug candidates.Methods: Employing a homogeneous, time-resolved fluorescence (hTRF) technique, we determined the selectivity of compound Via.We then conducted a cell-based assay using the huAPPswe/huBACE1 transgenic CHO cells to investigate the effect on the β-cleavage of APP.